Regulatory B cells (Bregs) and IL-10-producing B cells (B10s) antagonize anti-tumor immunity through similar Treg-related mechanisms: IL-10, TGF-β and PD-L1 expression [170,171]. Here, IL10 is linked to neoplasm.